These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22912337)
1. Ah receptor antagonism represses head and neck tumor cell aggressive phenotype. DiNatale BC; Smith K; John K; Krishnegowda G; Amin SG; Perdew GH Mol Cancer Res; 2012 Oct; 10(10):1369-79. PubMed ID: 22912337 [TBL] [Abstract][Full Text] [Related]
2. Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines. DiNatale BC; Schroeder JC; Perdew GH Mol Carcinog; 2011 Mar; 50(3):173-83. PubMed ID: 21104991 [TBL] [Abstract][Full Text] [Related]
3. The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines. John K; Lahoti TS; Wagner K; Hughes JM; Perdew GH Mol Carcinog; 2014 Oct; 53(10):765-76. PubMed ID: 23625689 [TBL] [Abstract][Full Text] [Related]
4. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential. Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090 [TBL] [Abstract][Full Text] [Related]
5. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells. To KK; Yu L; Liu S; Fu J; Cho CH Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497 [TBL] [Abstract][Full Text] [Related]
6. A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels. Tonigold M; Rossmann A; Meinold M; Bette M; Märken M; Henkenius K; Bretz AC; Giel G; Cai C; Rodepeter FR; Beneš V; Grénman R; Carey TE; Lage H; Stiewe T; Neubauer A; Werner JA; Brendel C; Mandic R J Cancer Res Clin Oncol; 2014 Oct; 140(10):1689-704. PubMed ID: 24913304 [TBL] [Abstract][Full Text] [Related]
7. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma. Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191 [TBL] [Abstract][Full Text] [Related]
8. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer. Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227 [TBL] [Abstract][Full Text] [Related]
9. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance. Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725 [TBL] [Abstract][Full Text] [Related]
10. EGFR regulates the side population in head and neck squamous cell carcinoma. Chen JS; Pardo FS; Wang-Rodriguez J; Chu TS; Lopez JP; Aguilera J; Altuna X; Weisman RA; Ongkeko WM Laryngoscope; 2006 Mar; 116(3):401-6. PubMed ID: 16540898 [TBL] [Abstract][Full Text] [Related]
13. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma. Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514 [TBL] [Abstract][Full Text] [Related]
14. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8. Huang J; Ji EH; Zhao X; Cui L; Misuno K; Guo M; Huang Z; Chen X; Hu S J Exp Clin Cancer Res; 2019 Mar; 38(1):138. PubMed ID: 30922366 [TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Ondrey FG; Dong G; Sunwoo J; Chen Z; Wolf JS; Crowl-Bancroft CV; Mukaida N; Van Waes C Mol Carcinog; 1999 Oct; 26(2):119-29. PubMed ID: 10506755 [TBL] [Abstract][Full Text] [Related]
16. KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma. Jiffar T; Yilmaz T; Lee J; Hanna E; El-Naggar A; Yu D; Myers JN; Kupferman ME Oncogene; 2011 Jul; 30(28):3163-73. PubMed ID: 21383688 [TBL] [Abstract][Full Text] [Related]
17. POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer. Sharpe DJ; Orr KS; Moran M; White SJ; McQuaid S; Lappin TR; Thompson A; James JA Oncotarget; 2014 Sep; 5(18):8803-15. PubMed ID: 25301728 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. Bourguignon LY; Wong G; Shiina M J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147 [TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas. Masuelli L; Budillon A; Marzocchella L; Mrozek MA; Vitolo D; Di Gennaro E; Losito S; Sale P; Longo F; Ionna F; Lista F; Muraro R; Modesti A; Bei R J Cell Physiol; 2012 Sep; 227(9):3344-53. PubMed ID: 22213373 [TBL] [Abstract][Full Text] [Related]
20. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma. Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]